BRIEF published on 01/26/2026 at 09:56, 4 days 5 hours ago Goldman Sachs crosses thresholds in Nanobiotix Voting Rights Goldman Sachs Crossing Thresholds NANOBIOTIX Off-market Acquisition
BRIEF published on 01/13/2026 at 22:20, 16 days 16 hours ago Nanobiotix's monthly information on shares and voting rights Voting Rights Euronext Actions Nasdaq NANOBIOTIX
BRIEF published on 01/13/2026 at 22:20, 16 days 16 hours ago Nanobiotix Reports Voting Rights and Share Capital Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE published on 01/13/2026 at 22:15, 16 days 16 hours ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. Listed on Euronext Paris and Nasdaq. Pioneering biotech company with disruptive therapeutic approaches Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 12/15/2025 at 08:35, 1 month 15 days ago NANOBIOTIX joins the CAC Mid 60 and SBF 120 indices Investors Biotechnology NANOBIOTIX CAC Mid 60 Stock Market Indices
BRIEF published on 12/15/2025 at 08:35, 1 month 15 days ago NANOBIOTIX to Enter CAC Mid 60 and SBF 120 Indices Euronext Paris Biotechnology SBF 120 NANOBIOTIX CAC Mid 60
PRESS RELEASE published on 12/15/2025 at 08:30, 1 month 15 days ago NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris Nanobiotix to join CAC Mid 60 and SBF 120 indices on Euronext Paris, enhancing visibility and market presence. CEO Laurent Levy expresses confidence in company's long-term strategy Euronext Paris SBF 120 NANOBIOTIX Index Inclusion CAC Mid 60
BRIEF published on 12/05/2025 at 15:54, 1 month 24 days ago Goldman Sachs reduces its stake in NANOBIOTIX Voting Rights Goldman Sachs Crossing Thresholds Transfer Of Shares NANOBIOTIX
BRIEF published on 11/17/2025 at 15:31, 2 months 12 days ago The Goldman Sachs Group reduces its stake in NANOBIOTIX Actions Goldman Sachs NANOBIOTIX 5% Threshold Title Loan
BRIEF published on 11/13/2025 at 22:20, 2 months 16 days ago Nanobiotix Advances Curadigm Nanoprimer Platform for Improved Drug Delivery Nanotechnology Drug Delivery NANOBIOTIX Curadigm Platform Therapeutic Vaccines
Published on 01/30/2026 at 14:00, 59 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 6 hours 24 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 6 hours 59 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 12 hours 44 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 14 hours 59 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 14:11, 48 minutes ago SBF AG expects stable to positive business development in a challenging environment for 2026
Published on 01/30/2026 at 13:30, 1 hour 28 minutes ago North Peak Expands Wabash Gold Mineralization at Prospect Mountain, Nevada
Published on 01/30/2026 at 12:00, 2 hours 59 minutes ago HSBC UK and Sage simplify tax reporting for small businesses ahead of Making Tax Digital
Published on 01/30/2026 at 11:54, 3 hours 5 minutes ago EQS-Adhoc: YOC AG: PRELIMINARY FIGURES FOR THE 2025 FINANCIAL YEAR
Published on 01/30/2026 at 10:30, 4 hours 29 minutes ago ASTA ENERGY SOLUTIONS AG SUCCESSFULLY COMPLETES IPO
Published on 01/29/2026 at 18:00, 20 hours 59 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 21 hours 14 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 21 hours 14 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
